Ebola vaccine trial begins in DR Congo
A clinical trial for an Ebola vaccine has begun in the Democratic Republic of Congo to address a severe outbreak. The trial aims to determine if the Ervebo vaccine provides cross-protection against the Bundibugyo strain of the virus.
Why it matters
The ongoing Ebola epidemic in the DRC represents a major public health crisis, and finding an effective vaccine is critical to saving lives.
Ebola vaccine trial begins in DR Congo left A health worker administers a dose of the Tumaini vaccine against the Ebola virus in Ituri, Congo, on October 23, 2026. AP AP https://th-i.thgim.com/public/incoming/lzodtp/article71617962.ece/alternates/FREE_1200/Congo_Ebola_9658_.jpg Dieudonne Dirole A health workers administers a dose of the Tumaini vaccine against Ebola virus, in Ituri, Congo, Friday, Oct. 23, 2026. (AP Photo/Dieudonne Dirole) Ervebo, a vaccine approved for use against the more common Zaire strain of Ebola, will be put through a full-scale human trial in the DRC to see if it offers any cross-protection against Bundibugyo Geneva, Switzerland The first clinical trial of an Ebola vaccine in the outbreak gripping the Democratic Republic of Congo began Friday (October 23, 2026), the head of the World Health Organisation said.
Headlinne story · 3 newsrooms
Democratic Republic of Congo Launches Clinical Trial for Ebola Vaccine
What every outlet reported, where they differ, and how each framed it →
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in